Revenue: The sum of all revenue fields included for a company's operating activities.
ARS Pharmaceuticals, Inc. (SPRY) had Revenue of $89.15M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
|
Revenue |
$89.15M |
$8.00M |
|
$0.98M |
|
$88.17M |
|
$92.23M |
|
$-3.08M |
|
$11.37M |
|
$8.29M |
|
$8.29M |
|
$8.00M |
|
$8.00M |
|
$8.00M |
|
$8.00M |
|
$-3.08M |
|
$-10.26M |
|
96.94M |
|
102.39M |
|
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
$334.30M |
|
$1.03M |
|
$16.86M |
|
$351.15M |
|
$23.44M |
|
$69.38M |
|
$70.92M |
|
$94.36M |
|
$256.80M |
|
$249.43M |
|
$256.80M |
|
97.95M |
|
| Cash Flow Statement Financials | |
$13.55M |
|
$-106.10M |
|
$72.40M |
|
$70.97M |
|
$50.82M |
|
$-20.15M |
|
$14.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.26 |
|
-- |
|
-- |
|
0.21 |
|
0.27 |
|
98.90% |
|
-3.46% |
|
-3.46% |
|
-11.51% |
|
9.29% |
|
8.97% |
|
$12.98M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
0.19 |
|
10.91 |
|
33.47 |
|
3.11% |
|
3.21% |
|
2.28% |
|
2.45% |
|
$2.62 |
|
$0.13 |
|
$0.13 |
|